January 22, 2026

Boston Scientific’s Seismiq Peripheral IVL System Introduced in Limited Market Release

January 22, 2026—Boston Scientific has initiated the limited market release of the Seismiq intravascular lithotripsy (IVL) system, marking the completion of the first peripheral cases using the device.

Catherine Jennings, President, Peripheral Vascular at Boston Scientific, announced the milestone on LinkedIn. Jennings stated that IVL technology has the potential to help physicians more effectively treat complex calcified disease, expanding options and improving procedural outcomes for patients.

According to the company’s online product page for Seismiq, the next-generation IVL system combines advanced deliverability, visibility, consistent acoustic profiles, and precise control for navigating challenging anatomies or delivering targeted therapy.

The device’s laser energy source is distributed through optical fibers, then converted to acoustic pressure waves by generating a plasma event when the laser energy hits each emitter’s metallic backstop within the balloon. The initial plasma plume fractures the calcium, while a secondary cavitation bubble further expands the fractures, noted the company.

Subscribe to our weekly newsletter.

Stay informed on the week's top stories including literature summaries, device approvals, guideline changes, and more. Plus, get our latest issues & supplements delivered to your inbox each month.

January 22, 2026

Boston Scientific’s Seismiq Peripheral IVL System Introduced in Limited Market Release

Current Issue

Keep In Touch